SuperworthDesign Therapeutics market cap DSGN
Share price times shares outstanding: what the whole company sells for, since 2021.
- Today, Oct 23, 2026
- $640.8M
- Highest close in our data
- $1.5B
- May 2021
Design Therapeutics is worth $640.8M at the close on Oct 23, 2026, at $10.24 a share.
That is up 96% over the last year and down 27% over five years.
Its highest close in our data was $1.5B in May 2021.
Market cap over time
Year by year
| Year | End of year | Low | High | Change |
|---|---|---|---|---|
| 2026 so far | $640.8M | $518.4M | $976.8M | +17% |
| 2025 | $548.6M | $164M | $556.5M | +55% |
| 2024 | $353.9M | $129.9M | $362.9M | +138% |
| 2023 | $148.4M | $112.5M | $524.4M | −74% |
| 2022 | $573.6M | $439.5M | $1.4B | −52% |
| 2021 | $1.2B | $792.5M | $1.5B | n/a |
Against its peers
Companies in Drug Manufacturers - General nearest Design Therapeutics' size, closest first, today.
| Company | Market cap |
|---|---|
| DSGNDesign Therapeutics | $640.8M |
| CRMDCorMedix | $611.9M |
| ZVRAZevra Therapeutics | $582.6M |
| IRWDIronwood Pharmaceuticals | $571.7M |
| PBYIPuma Biotechnology | $568.9M |
| COLLCollegium Pharmaceutical | $747.5M |
| ABUSArbutus Biopharma | $831M |
| ARVNArvinas | $477.3M |
| AMPHAmphastar Pharmaceuticals | $1.1B |
| OMEROmeros | $1.2B |
| PCRXPacira BioSciences | $1.5B |
| Peer median | $679.7M |
What the market cap tells you
Share price times shares outstanding: what the whole company sells for today.
Size, not quality. Large caps move slower and are covered more. That is all it tells you.
More on Design Therapeutics
Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.